Search research articles
Contact Us
Filters
Showing results (31-40 of 501) with videos related to
Page
of 51
Sort By:
Clinical and Experimental Pharmacology & Physiology
|
September 1, 1978
Effects of various drugs on the osmotic lysis of rat mast cells
R O Day, D N Wade
Journal of Chromatography
|
December 7, 1984
High-performance liquid chromatographic determination of a new anti-inflammatory agent, nabumetone, and its major metabolite in plasma using fluorimetric detection
J E Ray, R O Day
British Journal of Clinical Pharmacology
|
April 1, 1996
Experimental pain techniques
J S Walker, R O Day
British Journal of Clinical Pharmacology
|
October 1, 1990
D-penicillamine and D-penicillamine-protein disulphide in plasma and synovial fluid of patients with rheumatoid arthritis
D A Joyce, R O Day
The Journal of the Kansas Medical Society
|
March 1, 1979
Rational use of aspirin and nonsteroidal anti-inflammatory drugs in inflammatory arthritis
R O Day, H B Lindsley
The Medical Journal of Australia
|
February 28, 2006
Paracetamol should be first-line therapy in osteoarthritis
Richard O Day, Garry G Graham
British Journal of Clinical Pharmacology
|
August 8, 2006
Relationships between the adverse effects of drugs and genetic polymorphism in genes encoding drug metabolizing enzymes
John O Miners, Richard O Day
Therapeutic Drug Monitoring
|
May 1, 1990
Compliance with criteria necessary for effective drug concentration monitoring
G A Pearce, R O Day
Agents and Actions. Supplements
|
January 1, 1985
Stereoselective disposition--basis for variability in response to NSAID's
K M Williams, R O Day
Drug Safety
|
April 8, 1998
The application of adverse drug reaction data to drug choice decisions made by pharmacy and therapeutics committees. An Australian perspective
L M Weekes, R O Day
Page
of 51
Search research articles
Search
Showing results (31-40 of 501) with videos related to
Sort By:
Page
of 51
Clinical and Experimental Pharmacology & Physiology
|
September 1, 1978
Effects of various drugs on the osmotic lysis of rat mast cells
R O Day, D N Wade
Journal of Chromatography
|
December 7, 1984
High-performance liquid chromatographic determination of a new anti-inflammatory agent, nabumetone, and its major metabolite in plasma using fluorimetric detection
J E Ray, R O Day
British Journal of Clinical Pharmacology
|
April 1, 1996
Experimental pain techniques
J S Walker, R O Day
British Journal of Clinical Pharmacology
|
October 1, 1990
D-penicillamine and D-penicillamine-protein disulphide in plasma and synovial fluid of patients with rheumatoid arthritis
D A Joyce, R O Day
The Journal of the Kansas Medical Society
|
March 1, 1979
Rational use of aspirin and nonsteroidal anti-inflammatory drugs in inflammatory arthritis
R O Day, H B Lindsley
The Medical Journal of Australia
|
February 28, 2006
Paracetamol should be first-line therapy in osteoarthritis
Richard O Day, Garry G Graham
British Journal of Clinical Pharmacology
|
August 8, 2006
Relationships between the adverse effects of drugs and genetic polymorphism in genes encoding drug metabolizing enzymes
John O Miners, Richard O Day
Therapeutic Drug Monitoring
|
May 1, 1990
Compliance with criteria necessary for effective drug concentration monitoring
G A Pearce, R O Day
Agents and Actions. Supplements
|
January 1, 1985
Stereoselective disposition--basis for variability in response to NSAID's
K M Williams, R O Day
Drug Safety
|
April 8, 1998
The application of adverse drug reaction data to drug choice decisions made by pharmacy and therapeutics committees. An Australian perspective
L M Weekes, R O Day
Page
of 51